Story perspectives
79-Year-Old Gets Retatrutide; Trump Denied Involvement Amid Allocation Pressure
7/10/2026
1 of 2
Patient Secures Retatrutide
- A 79-year-old patient obtained the obesity drug retatrutide through FDA compassionate use as 25 stations launched the Freedom Fuel Network.
- The White House said President Donald Trump did not receive retatrutide and had no role in the Freedom Fuel Network.
- Kush Desai and Steven Cheung rebuked speculation, confirming the drug was not for the President.
- Rep. Ted Lieu and Sen. Maggie Hassan wrote letters, alleging pressure over drug’s allocation.
1 / 2
